Chemoradiation of late T2 or early T3 glottic cancer combination with S-1

Chemoradiation of late T2 or early T3 glottic cancer combination with S-1 - T2-3KKK S-1-RT_P2

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008605

Enrollment

Registered

2012-08-03

Start date

2014-07-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glottic cancer

Interventions

chemoradiation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: T2-3 glottic cancer

Exclusion criteria

Exclusion criteria: over 81 year-old

Design outcomes

Primary

Measure	Time frame
2-year progression free survival rate	—

Countries

Japan

Contacts

Public ContactTatsuya Nakamura

Southern Tohoku Hospital radiation oncology

tatsuya.nakamura@nifty.com024-934-3888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026